Akihisa Harada News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Japan: Pfizer seeks fast-track vaccine approval

US pharmaceutical first to seek approval in Japan, with vaccination expected to start in March Riyaz ul Khaliq | 18.12.2020 ANKARA US drug maker Pfizer on Friday requested Japanese government approval of its vaccine to treat the deadly coronavirus, local media reported. The company filed an application for fast-track approval of the vaccine in the country, which has reported nearly 187,103 cases, including 2,739 deaths, since the outbreak of the COVID-19 pandemic. It is the first drug manufacturer to apply for vaccine approval in Japan, Kyodo News reported. “We will strictly screen the effectiveness and safety [of the vaccine] before making a judgment,” Japan’s Health, Labor and Welfare Minister Norihisa Tamura told a news conference.

Akihisa haradaNorihisa tamuraJapan healthKyodo newsWelfare minister norihisa tamuraஜப்பான் ஆரோக்கியம்கியோடோ செய்தி

Pfizer files request for COVID-19 vaccine approval in Japan

Pfizer files request for COVID-19 vaccine approval in Japan Dec. 18, 2020 12:35 pm JST Jan. 13 | 02:56 pm JST TOKYO The requested article has expired, and is no longer available. Any related articles, and user comments are shown below. © KYODO ©2021 GPlusMedia Inc. In response to the surge in infections across Japan, Prime Minister Yoshihide Suga s administration said the PM had recently enjoyed a steak dinner in the company of fellow geriatrics, contrary to guidelines and common sense, for someone meant to be showing leadership. 20 ( +27 / -7 ) Dec. 18, 2020 07:08 am JST Japan needs to speed up the procedures and start vaccinating before March. Priority first healthcare workers and old folk homes. Front line workers. Pfizer vaccine is for 16 years and older. Two shots 21 days apart. The immunity is about a week after the second shot.

United statesUnited kingdomAkihisa haradaJapan ministry of healthPfizer inc onPfizer incஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்ஜப்பான் அமைச்சகம் ஆஃப் ஆரோக்கியம்ஃபைசர் இன்க் ஆன்ஃபைசர் இன்க்

Pfizer seeks vaccine approval in Japan

Pfizer seeks vaccine approval in Japan 3 First jabs for 60m Japanese could start in March, says health ministry published : 18 Dec 2020 at 18:16 (Photo: Reuters) TOKYO: The US pharmaceutical maker Pfizer Inc has asked Japan’s health ministry to approve its Covid-19 vaccine, making it the first drugmaker to file such a request in the country. If approved, vaccinations could begin in Japan as early as March, government officials said on Friday. Japan has already agreed with Pfizer to receive a supply of 120 million doses in the first half of next year, enough for 60 million people, or roughly half of the population.

United statesUnited kingdomAkihisa haradaNorihisa tamuraPfizer incMinister norihisa tamuraஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்ஃபைசர் இன்க்

Pfizer seeks fast-track approval in Japan of COVID-19 vaccine

Pfizer seeks fast-track approval in Japan of COVID-19 vaccine
japanherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japanherald.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAkihisa haradaNorihisa tamuraPfizer incஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்ஃபைசர் இன்க்

Pfizer seeks fast-track approval in Japan of COVID-19 vaccine - World News

2020-12-18 11:06:16 GMT2020-12-18 19:06:16(Beijing Time) Xinhua English TOKYO, Dec. 18 (Xinhua) U.S. pharmaceutical giant Pfizer Inc. has become the first drugmaker to seek approval for the use of its COVID-19 vaccine in Japan by filing a request with the health ministry on Friday. Pfizer is seeking a fast-track approval, meaning that based on the fact that its vaccine has been approved in other countries, it won t have to conduct large scale clinical trials here. The vaccine, which has been developed jointly by Pfizer and its German partner BioNTech SE, has already been rolled out across Britain and the United States.

United statesUnited kingdomAkihisa haradaNorihisa tamuraPfizer incஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்ஃபைசர் இன்க்